Jon Alm Eriksen
University of Oslo
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jon Alm Eriksen.
JAMA Psychiatry | 2017
Olav B. Smeland; Oleksandr Frei; Karolina Kauppi; W. David Hill; Wen Li; Yunpeng Wang; Florian Krull; Francesco Bettella; Jon Alm Eriksen; Aree Witoelar; Gail Davies; Chun Chieh Fan; Wesley K. Thompson; Max Lam; Todd Lencz; Chi-Hua Chen; Torill Ueland; Erik G. Jönsson; Srdjan Djurovic; Ian J. Deary; Anders M. Dale; Ole A. Andreassen
Importance Schizophrenia is associated with widespread cognitive impairments. Although cognitive deficits are one of the factors most strongly associated with functional outcome in schizophrenia, current treatment strategies largely fail to ameliorate these impairments. To develop more efficient treatment strategies in patients with schizophrenia, a better understanding of the pathogenesis of these cognitive deficits is needed. Accumulating evidence indicates that genetic risk of schizophrenia may contribute to cognitive dysfunction. Objective To identify genomic regions jointly influencing schizophrenia and the cognitive domains of reaction time and verbal-numerical reasoning, as well as general cognitive function, a phenotype that captures the shared variation in performance across cognitive domains. Design, Setting, and Participants Combining data from genome-wide association studies from multiple phenotypes using conditional false discovery rate analysis provides increased power to discover genetic variants and could elucidate shared molecular genetic mechanisms. Data from the following genome-wide association studies, published from July 24, 2014, to January 17, 2017, were combined: schizophrenia in the Psychiatric Genomics Consortium cohort (n = 79 757 [cases, 34 486; controls, 45 271]); verbal-numerical reasoning (n = 36 035) and reaction time (n = 111 483) in the UK Biobank cohort; and general cognitive function in CHARGE (Cohorts for Heart and Aging Research in Genomic Epidemiology) (n = 53 949) and COGENT (Cognitive Genomics Consortium) (n = 27 888). Main Outcomes and Measures Genetic loci identified by conditional false discovery rate analysis. Brain messenger RNA expression and brain expression quantitative trait locus functionality were determined. Results Among the participants in the genome-wide association studies, 21 loci jointly influencing schizophrenia and cognitive traits were identified: 2 loci shared between schizophrenia and verbal-numerical reasoning, 6 loci shared between schizophrenia and reaction time, and 14 loci shared between schizophrenia and general cognitive function. One locus was shared between schizophrenia and 2 cognitive traits and represented the strongest shared signal detected (nearest gene TCF20; chromosome 22q13.2), and was shared between schizophrenia (z score, 5.01; P = 5.53 × 10−7), general cognitive function (z score, –4.43; P = 9.42 × 10−6), and verbal-numerical reasoning (z score, –5.43; P = 5.64 × 10−8). For 18 loci, schizophrenia risk alleles were associated with poorer cognitive performance. The implicated genes are expressed in the developmental and adult human brain. Replicable expression quantitative trait locus functionality was identified for 4 loci in the adult human brain. Conclusions and Relevance The discovered loci improve the understanding of the common genetic basis underlying schizophrenia and cognitive function, suggesting novel molecular genetic mechanisms.
Journal of the American Academy of Child and Adolescent Psychiatry | 2017
Alexey A. Shadrin; Olav B. Smeland; Tetyana Zayats; Andrew J. Schork; Oleksandr Frei; Francesco Bettella; Aree Witoelar; Wen Li; Jon Alm Eriksen; Florian Krull; Srdjan Djurovic; Stephen V. Faraone; Ted Reichborn-Kjennerud; Wesley K. Thompson; Stefan Johansson; Jan Haavik; Anders M. Dale; Yunpeng Wang; Ole A. Andreassen
OBJECTIVE Attention-deficit/hyperactivity disorder (ADHD) is a common and highly heritable psychiatric condition. By exploiting the reported relationship between ADHD and educational attainment (EA), we aimed to improve discovery of ADHD-associated genetic variants and to investigate genetic overlap between these phenotypes. METHOD A conditional/conjunctional false discovery rate (condFDR/conjFDR) method was applied to genome-wide association study (GWAS) data on ADHD (2,064 trios, 896 cases, and 2,455 controls) and EA (n=328,917) to identify ADHD-associated loci and loci overlapping between ADHD and EA. Identified single nucleotide polymorphisms (SNPs) were tested for association in an independent population-based study of ADHD symptoms (n=17,666). Genetic correlation between ADHD and EA was estimated using LD score regression and Pearson correlation. RESULTS At levels of condFDR<0.01 and conjFDR<0.05, we identified 5 ADHD-associated loci, 3 of these being shared between ADHD and EA. None of these loci had been identified in the primary ADHD GWAS, demonstrating the increased power provided by the condFDR/conjFDR analysis. Leading SNPs for 4 of 5 identified regions are in introns of protein coding genes (KDM4A, MEF2C, PINK1, RUNX1T1), whereas the remaining one is an intergenic SNP on chromosome 2 at 2p24. Consistent direction of effects in the independent study of ADHD symptoms was shown for 4 of 5 identified loci. A polygenic overlap between ADHD and EA was supported by significant genetic correlation (rg=-0.403, p=7.90×10-8) and >10-fold mutual enrichment of SNPs associated with both traits. CONCLUSION We identified 5 novel loci associated with ADHD and provided evidence for a shared genetic basis between ADHD and EA. These findings could aid understanding of the genetic risk architecture of ADHD and its relation to EA.
European Neuropsychopharmacology | 2017
Olav B. Smeland; Karolina Kauppi; Yunpeng Wang; W. David Hill; Gail Davies; Oleksandr Frei; Wen Li; Jon Alm Eriksen; Aree Witoelar; Francesco Bettella; Chun C. Fan; Wes Thompson; Chi-Hua Chen; Srdjan Djurovic; Ian J. Deary; Anders M. Dale; Ole A. Andreassen
Background: Schizophrenia (SCZ) is a severe mental disorder characterized by widespread cognitive impairments including deficits in learning, memory, processing speed, attention and executive funct ...
Physical Review E | 2015
Jon Alm Eriksen; Benjy Marks; Bjornar Sandnes; Renaud Toussaint
Physical Review E | 2015
Jon Alm Eriksen; Renaud Toussaint; Knut Jørgen Måløy; Eirik G. Flekkøy; Bjornar Sandnes
Journal of Fluid Mechanics | 2017
Benjy Marks; Jon Alm Eriksen; Guillaume Dumazer; Bjornar Sandnes; Knut Jørgen Måløy
European Neuropsychopharmacology | 2017
Jon Alm Eriksen; Francesco Bettella; Wesley K. Thompson; Yunpeng Wang; Aree Witoelar; Olav B. Smeland; Oleksandr Frei; Srdjan Djurovic; Anders M. Dale; Ole A. Andreassen
Archive | 2014
Bjornar Sandnes; Knut Jørgen Måløy; Eirik G. Flekkøy; Jon Alm Eriksen
Physical Review E | 2010
Jon Alm Eriksen; Soumyajyoti Biswas; Bikas K. Chakrabarti
Physical Review E | 2010
Jon Alm Eriksen; Soumyajyoti Biswas; Bikas K. Chakrabarti